

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | £0.78 | £372.04 £279.03 Free shipping | |
| 180 pills | £0.86 | £206.68 £155.01 Free shipping | |
| 120 pills | £0.95 | £152.06 £114.04 | |
| 90 pills | £1.06 | £126.96 £95.22 | |
| 60 pills | £1.18 | £94.48 £70.86 | |
| 30 pills | £1.47 | £59.04 £44.28 | |
| 180 pills | £1.30 | £311.51 £233.63 Free shipping | |
| 120 pills | £1.38 | £221.45 £166.09 Free shipping | |
| 90 pills | £1.49 | £180.11 £135.08 | |
| 60 pills | £1.68 | £134.34 £100.75 | |
| 30 pills | £2.07 | £82.66 £62.00 | |
| 180 pills | £1.48 | £355.80 £266.85 Free shipping | |
| 120 pills | £1.57 | £250.98 £188.23 Free shipping | |
| 90 pills | £1.80 | £217.02 £162.76 Free shipping | |
| 60 pills | £2.17 | £174.20 £130.65 | |
| 30 pills | £2.90 | £116.62 £87.47 | |
| 120 pills | £3.18 | £507.87 £380.91 Free shipping | |
| 90 pills | £3.38 | £406.00 £304.50 Free shipping | |
| 60 pills | £3.86 | £308.56 £231.42 Free shipping | |
| 30 pills | £4.93 | £197.83 £148.37 Free shipping | |
| 90 pills | £4.53 | £543.31 £407.48 Free shipping | |
| 60 pills | £4.87 | £389.76 £292.32 Free shipping | |
| 30 pills | £6.12 | £245.07 £183.80 Free shipping |
Disclaimer: This information is intended for patients in the United Kingdom and should not replace professional medical advice. Always consult a clinician for personalised guidance.
What if mood instability and sleep disturbance could be managed with a single medicine? Seroquel, containing the active ingredient quetiapine, is an antipsychotic (a drug used to treat certain mental health conditions) that helps balance brain chemicals to improve mood, sleep, and behaviour in selected contexts.
Quetiapine belongs to the class of atypical antipsychotics (newer generation medicines for psychotic symptoms) and is used under medical supervision to treat conditions such as schizophrenia and bipolar disorder. It may also be prescribed as an add‑on treatment in certain circumstances of major depressive disorder.
Quetiapine is supplied in tablet form and may be available in immediate‑release and extended‑release versions. The precise formulation and dose are determined by a clinician based on individual needs and response. This information sheet describes common considerations for UK patients and should be read with the official patient leaflet supplied with the medicine.
Administration requires careful monitoring by a clinician due to potential side effects and interactions. The information provided here does not replace professional advice from a pharmacist or doctor.
Quetiapine is used to treat schizophrenia (a chronic mental health condition with symptoms such as delusions, hallucinations, and disordered thinking) and bipolar disorder (episodes of mood shifts from depressive lows to mania or hypomania). In some cases, it is used to support depressive symptoms when other treatments have not achieved the desired response.
In the United Kingdom, quetiapine may be prescribed as an adjunct to antidepressants for certain depressive episodes when symptoms persist. It is also used in special early or urgent care pathways under specialist supervision. The exact indication depends on clinical assessment and local guidelines.
As with all medicines, the potential benefits are weighed against possible risks. Therapeutic response varies between individuals and may require ongoing assessment by a clinician to determine whether continued treatment remains appropriate.
It should be understood that quetiapine is not a cure for these conditions. The aim is to reduce symptoms, improve daily functioning, and support overall well‑being. Any anticipated outcomes are discussed with the prescriber and monitored over time.
Before starting quetiapine, a clinician assesses medical history, current medications, and potential risk factors. This includes checking for conditions such as heart disease, diabetes, seizures, liver problems, and movement disorders. The assessment helps determine suitability and safe dosing.
Clinical evaluation also covers current mental health status, history of adverse reactions to antipsychotic medicines, and potential interactions with substances such as alcohol. A plan for monitoring may be created, including routine follow‑up and objective measures where appropriate.
Allergies and tolerances to active or inactive ingredients are reviewed. Patients should inform the clinician of any other prescribed medicines, over‑the‑counter products, or herbal supplements being used. This information supports a safe and effective treatment plan.
In some cases, a baseline examination (for example, weight, blood pressure, and blood tests) may be suggested to establish reference points before initiating therapy. The exact approach depends on individual health needs and local practice.
The dose is started cautiously and adjusted over days to weeks under supervision. The exact amounts are individualized and described in the official patient information leaflet. Urgent changes should not be made without professional advice.
During titration, attention is paid to therapeutic response and tolerability. Some patients may experience withdrawal or rebound symptoms if a dose is reduced too quickly. The clinician will provide guidance on how to manage any uncomfortable effects.
Concomitant medicines may influence dosing decisions. If another medicine is added or removed, the clinician may adjust the quetiapine dose accordingly. Routine monitoring is commonly recommended during dose changes or when other medications are started or stopped.
Patients are advised to report new or worsening symptoms, unusual movement patterns, or excessive sedation promptly. Decisions about continuing, adjusting, or stopping treatment are made in partnership with the clinician, based on clinical needs.
Quetiapine is typically taken once or twice daily, with timing chosen by the prescriber. Tablets may be taken with or without food, depending on formulation and advice. It is important to take the medicine at the same time each day to maintain even levels in the body.
Taking quetiapine with food can slightly affect absorption for certain formulations, but the primary objective is consistent daily use. If a dosing schedule is missed or changes, the plan should be discussed with a clinician to avoid gaps in effectiveness.
Stopping quetiapine abruptly is generally not advised. A gradual taper under medical supervision reduces the risk of withdrawal symptoms or symptom recurrence. Any plan to discontinue should be discussed with the prescriber or pharmacist.
Precautions apply to activities requiring alertness. Drowsiness, dizziness, or impaired coordination can occur, especially at the start of therapy or after dose changes. It is prudent to avoid driving or operating heavy machinery until a clear pattern of tolerance is established.
If a dose is missed, the plan depends on how long has passed since the missed dose. If many hours have passed, the missed dose is generally skipped and the next scheduled dose should be taken at the usual time. Do not double up without consulting a clinician.
If the next dose is due soon, it may be advised to continue with the regular dosing schedule and not to take extra doses to make up for the missed one. Guidance may differ for certain regimens, so checking with a pharmacist or clinician is recommended.
In the event of repeated missed doses, or if there is ongoing difficulty maintaining a regular schedule, contact the prescriber for advice. An adjustment to the dosing plan or support with reminders may be discussed.
Patients are encouraged to have a clear plan for missed doses when travelling or facing disruptions in daily routines. This helps maintain therapeutic levels and reduces the risk of symptom return.
Initial effects may be modest and gradual. Sleep patterns can change within days, and improvements in agitation or racing thoughts may be noticed earlier in some individuals. Mood stabilization often develops over several weeks with ongoing treatment and monitoring.
Common early effects include drowsiness or sedation, which tends to lessen with time as the body adjusts. Some patients may experience dizziness, lightheadedness on standing, or mild headaches during the initial period.
Weight changes, appetite shifts, and metabolic effects may occur; monitoring weight, blood pressure, and metabolic factors is often recommended during treatment. Lifestyle strategies, such as regular meals and physical activity, may support overall health.
Behavioural changes or improved sleep can contribute to better daytime functioning, but the full therapeutic effect for mood symptoms may require ongoing treatment under supervision and may include adjustments to dose or additional therapies. Communication with the clinician is important to evaluate progress and tolerability over time.
Quetiapine can interact with other medicines and substances. A full medication history helps identify potential interactions. The clinician may advise adjusting doses or timing when certain medicines are used together.
Major contraindications include known hypersensitivity to quetiapine or formulation ingredients and certain medical conditions that increase the risk of adverse effects. The following cautions are important but do not replace professional advice.
Potential interactions can occur with alcohol, centrally acting depressants, other antipsychotics, and medicines that affect heart rhythm or liver enzymes. Clinical monitoring is advised when starting or stopping interacting medicines.
Common cautions include the risk of metabolic changes, movement disorders such as tardive dyskinesia with long‑term use, and sedation. The risk may be higher in older adults or those with pre‑existing conditions. Regular review helps to ensure safety and effectiveness.
Store quetiapine in its original packaging to protect from moisture and light. Keep the bottle or blister pack tightly closed when not in use. Do not store above room temperature unless advised by the packaging leaflet.
Keep all medicines out of reach and sight of children and away from pets. Do not take medicines after their expiry date or if the packaging shows signs of damage. If there is any doubt, consult a pharmacist for guidance.
Unused or expired tablets should be disposed of according to local guidelines. Do not flush medicines down the toilet unless specifically instructed. The pharmacist can provide safe disposal options if needed.
Always follow the storage instructions provided with the product and check the official leaflet for any formulation‑specific requirements. If there is any uncertainty, seek advice from a pharmacist or clinician before use.
In pregnancy, the potential benefits and risks to the fetus must be discussed with a clinician. Quetiapine may be considered when the expected benefits justify potential risks, and alternatives are weighed. If pregnancy occurs during treatment, consultation is advised promptly.
Breastfeeding while taking quetiapine should be discussed with a clinician. It is not clear how much of the medicine passes into breast milk, and the decision depends on the mother’s condition and the infant’s health.
In elderly patients, there may be higher sensitivity to sedation, dizziness, and metabolic changes. Dose adjustments and closer monitoring can be required in this group. In liver or kidney impairment, careful evaluation is undertaken to decide on appropriate dosing and monitoring needs.
All special populations require carefully tailored plans. The clinician may adjust the treatment approach based on medical history, concomitant conditions, and the patient’s response to therapy.
When traveling, maintain a consistent dosing routine and carry enough medication for the trip, plus a copy of the prescription or a letter from the clinician if required. Keeping the medication in its original packaging helps with identification and safety checks.
Carry a basic plan for missed doses and disruptions in routine. If time zones change, coordinate dose timing with the clinician to maintain a regular schedule and avoid inadvertent double dosing or gaps in treatment.
Carry contact details for the clinician or pharmacist in case of questions or adverse effects while away from home. If there is any concern about interaction with activities such as driving or operating machinery, assess tolerance before engaging in such activities.
OTC medicines and herbal products should be discussed with a pharmacist before use. Some common substances can interact with quetiapine or affect its absorption, metabolism, or clearance from the body. A coordinated plan helps prevent adverse effects.
Alcohol can increase sedation and may worsen dizziness or low blood pressure. It is generally advised to limit or avoid alcohol while on quetiapine unless a clinician has provided explicit, individualized guidance.
If a dose is missed, the plan depends on how long since the missed dose occurred. In many cases, the next scheduled dose should be taken at the usual time, and a double dose should not be taken to make up for the missed one. Consult a clinician if there are doubts.
Drowsiness or dizziness can occur, particularly early in treatment or after changes in dose. It is prudent to assess personal tolerance before driving or operating potentially dangerous machinery. If sedation is present, alternative arrangements may be considered until tolerance improves.
Interactions can occur with certain medicines, including antidepressants, sedatives, and drugs that affect heart rhythm or liver enzymes. A full medication review is essential before combining therapies. Always inform the pharmacist about all medicines being used.
Improvements in sleep and agitation may be noticed within days, while mood stabilization and broader symptom relief can take several weeks. Persistent symptoms despite treatment warrant review by a clinician to determine next steps.
Tablet form is designed to be swallowed whole. Some immediate‑release formulations may be scored, allowing careful splitting if advised by a clinician. Extended‑release (XR) forms should not be crushed or chewed, as this can alter the release of the medicine.
Whether to take with food depends on the specific formulation and guidance from the prescriber. General practice often supports taking the medicine at a consistent time with or without food to maintain stable absorption, following the product leaflet.
Risks and benefits must be weighed carefully during pregnancy and breastfeeding. A clinician will discuss potential effects on the fetus or infant and consider alternative options if appropriate. Do not start or stop treatment without professional advice during pregnancy or breastfeeding.
Keep quetiapine in its original packaging, at stable room temperature, and protected from moisture and heat. Carry the medication in a way that prevents loss or damage and have access to the prescription details if required by authorities or travel insurers.
Inform the dentist about current medications, including quetiapine, because sedation effects or interactions with anesthetics and pain medicines can occur. This helps plan care and avoid unexpected interactions during procedures.
Weight gain and changes in blood sugar or cholesterol can occur with some patients. Regular monitoring, including weight checks and, if indicated, metabolic testing, may be recommended. Lifestyle measures such as balanced diet and physical activity can support overall health.
Any signs of a serious allergic reaction should prompt urgent medical evaluation. Seek immediate medical help if swelling of the face or throat, severe rash, or difficulty breathing occurs. A clinician can determine whether to continue or adjust treatment.
Metabolic monitoring is often advised, especially for individuals with existing risk factors. The clinician may order tests to assess blood sugar and lipid levels, and to guide any necessary lifestyle or treatment adjustments.
Switching should be planned and supervised by a clinician. A cross‑titration approach is sometimes used to minimise withdrawal effects and symptom recurrence. The exact transition schedule depends on the specific medicines involved and the patient’s health status.
Blood donation guidelines vary by country and depend on health status and current medications. A clinician or donor centre can provide personalised advice based on local policies and an individual health assessment.
The decision to continue long‑term treatment is made by the clinician based on clinical history, risk of relapse, and functional goals. Regular reviews are recommended to determine whether ongoing therapy remains appropriate and safe.
In the event of medical emergencies, present the current medications to the treating team, as quetiapine can interact with other therapies used in urgent care. The clinician will coordinate care and monitor for relevant interactions or side effects.
Persistent or troublesome side effects warrant prompt communication with a clinician. The treatment plan may be adjusted, including dose changes, switching to an alternative medicine, or adding supportive therapies to improve tolerability and outcomes.
Discontinuation should be managed with professional guidance. Abrupt stopping can lead to withdrawal symptoms and relapse of psychiatric symptoms. A gradual taper under supervision is usually recommended.
Additional information can be obtained from the official patient information leaflet accompanying the medicine, local pharmacy services, and healthcare professionals such as the GP or psychiatrist. If any uncertainties remain, contact a pharmacist for clarification.
14–21 days. Free from £147.64 .
5–9 days. £22.15
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
